DG vs FATE · P/E 15, rev $22.08B vs rev $3.4M
Dollar General Corporation (DG) versus Fate Therapeutics Inc (FATE) — a side-by-side from cached financials, not a winner call.
Dollar General Corporation (DG) is a discount stores company listed on US.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Latest reported DG revenue for 2026-07-31 was $22.08B. Net income was $994.4M. DG currently screens at market cap $22.87B and trailing P/E 14.7.
Latest reported FATE revenue for 2026-06-30 was $3.4M. Net income was -$61.4M. FATE currently screens at market cap $331.0M.
DG currently screens at market cap $22.87B and trailing P/E 14.7. FATE currently screens at market cap $331.0M.
Not investment advice. Open the DG and FATE stock pages for the full models.
Not investment advice.